Arthur Hayes, co-founder of the cryptocurrency exchange BitMEX, has intensified his involvement in the biotechnology sector by becoming a board member and a major investor in a company specializing in stem cell treatment. He shared this in an interview with Bloomberg.
This is reported by Business • Media
Hayes Does Not Reveal the Company’s Name but Actively Uses Its Services
Hayes refrained from naming the company as it is currently undergoing a rebranding process. It is known that its operations are based in Mexico and Bangkok. The entrepreneur not only invests in the company but is also a client — for about a year, he has been regularly attending procedures aimed at extending life.
“I want to live as long as possible and be as healthy as I can. This is the future — you see more and more countries easing regulations on the use of stem cells.”
Notable Crypto Entrepreneurs Invest in Biotechnology
In addition to Arthur Hayes, the article notes that Ethereum co-founder Vitalik Buterin donated $2.4 million to the SENS Research Foundation in 2018, which funds research in the field of life extension and regenerative medicine. Additionally, Coinbase CEO Brian Armstrong founded NewLimit, which raised $130 million in May 2025 to develop therapies that slow human aging.
During the interview, Arthur Hayes commented on his pardon by former U.S. President Donald Trump: although he was sentenced in 2022 to probation and a $10 million fine for violating the Bank Secrecy Act, his life has hardly changed since the pardon in March 2025. He also highlighted the risks associated with the boom of treasury companies and expressed support for the Trump family’s initiatives in the field of crypto assets.